Literature DB >> 6169643

Radioimmunoassay for human beta interferon.

M Inoue, Y H Tan.   

Abstract

Pure human beta interferon (Hu IFN-beta) (formerly human fibroblast interferon) was used to raise antibodies in rabbits. Anti-IFN-beta immunoglobulins from rabbit serum were purified by IFN-beta affinity chromatography and were used in the development of a sandwich-type radioimmunoassay for Hu IFN-beta. This radioimmunoassay consisted of (i) incubating Hu IFN-beta with anti-IFN-beta immunoglobulins immobilized on Sepharose 4B beads and (ii) incubating the resulting solid-phase IFN antibody complex with 125I-labeled anti-Hu IFN-beta immunoglobulins. The amount of 125I-labeled anti-Hu IFN-beta bound to the complex was linearly proportional to the amount of antiviral activity present in the complex from 0 to 500 U of standard IFN-beta per ml; 1 U of antiviral activity was equivalent to about 40 cpm of 125I-labeled anti-IFN immunoglobulins in the radioimmunoassay. The results of the radioimmunoassay were not influenced by the protein content of the IFN sample assayed, and the degree of intraassay variability was low; coefficients of variability were 9.4% at 5 U/ml and 1.1% at 500 U/ml. Thus, compared with the traditional antiviral assay for IFN, this radioimmunoassay was equally sensitive and more precise. In addition, it was highly specific for Hu IFN-beta and took only 5 h to complete.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6169643      PMCID: PMC350775          DOI: 10.1128/iai.33.3.763-768.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Comparison of the effects of various detergents on antigen-antibody interaction.

Authors:  M J. Crumpton; R M.E. Parkhouse
Journal:  FEBS Lett       Date:  1972-05-01       Impact factor: 4.124

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Interferon: purification and initial characterization from human diploid cells.

Authors:  E Knight
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

4.  Effect of detergents on antibody-antigen interaction.

Authors:  G J Dimitriadis
Journal:  Anal Biochem       Date:  1979-10-01       Impact factor: 3.365

5.  Immunoradiometric and two-site assay of human follicle-stimulating hormone.

Authors:  C Readhead; G M Addison; C N Hales; H Lehmann
Journal:  J Endocrinol       Date:  1973-11       Impact factor: 4.286

6.  Solubilization of membrane proteins by sulfobetaines, novel zwitterionic surfactants.

Authors:  A Gonenne; R Ernst
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

7.  Preparation of 125iodine-labelled human fibroblast interferon.

Authors:  E Knight
Journal:  J Gen Virol       Date:  1978-09       Impact factor: 3.891

8.  Purification and in vitro labeling of interferon from a human fibroblastoid cell line.

Authors:  W Berthold; C Tan; Y H Tan
Journal:  J Biol Chem       Date:  1978-07-25       Impact factor: 5.157

9.  Human fibroblastoid interferon: immunosorbent column chromatography and N-terminal amino acid sequence.

Authors:  H Okamura; W Berthold; L Hood; M Hunkapiller; M Inoue; H Smith-Johannsen; Y H Tan
Journal:  Biochemistry       Date:  1980-08-05       Impact factor: 3.162

10.  Regulation of cellular interferon production: enhancement by antimetabolites.

Authors:  Y H Tan; J A Armstrong; Y H Ke; M Ho
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

View more
  2 in total

1.  Immunoradiometric assay of a recombinant human alpha-2 interferon (SCH 30500).

Authors:  W P Protzman; M Minnicozzi; S L Jacobs; D I Surprenant; J Schwartz; E M Oden
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

2.  Rapid and transient rise in diacylglycerol concentration in Daudi cells exposed to interferon.

Authors:  W H Yap; T S Teo; E McCoy; Y H Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.